Annual Report 2023-2024 available

Advancing Tick-Borne Disease Research: Insights & Progress Event 30 April

Donate My Account

Help us develop breakthrough therapies for brain cancer patients

Support revolutionary brain cancer treatment through innovative research that significantly improves survival rates and quality of life for patients.
Asian male in scientific lab
Beneficiary Kolling Institute
Active projects at facility 5 Projects
View Facility
79%
Our goal $200,000
Raised $157,920
To go $42,080

Project Overview

You can play a critical role in advancing novel therapies that aim to dramatically improve survival rates and quality of life for individuals affected by brain cancer.

Under the leadership of Dr. Julius W. Kim, his team focuses on rapidly translating innovative therapeutic strategies into clinical treatments. His current groundbreaking projects include:

  • Adenoviral vectors for targeted therapy
    Developing cell-specific adenoviral vectors that act as highly efficient delivery systems or cancer-targeting mechanisms, offering precision in treatment.
  • Brain cancer vaccine therapy
    Pioneering a vaccine therapy that stimulates the immune system to identify and destroy brain tumors, providing a powerful new weapon in the fight against cancer.
  • Viro-immunotherapy
    Creating viro-immunotherapy treatments designed to selectively kill cancerous cells while simultaneously enhancing the body’s immune response to combat brain cancer.

By supporting these projects, you contribute to a future where brain cancer patients can access cutting-edge therapies that offer hope for longer, healthier lives.

Why your support matters?

The urgent need for effective brain cancer treatments

Brain cancer is the leading cause of cancer-related deaths among Australian children, and despite advancements in other medical therapies, the survival rate for brain cancer remains extremely poor. This disease continues to claim the lives of more children than any other form of cancer, highlighting the urgent need for more effective treatment options.

Innovative therapeutic approaches

Dr. Kim's team has developed innovative, brain cancer-specific therapeutic approaches that have never been explored before. These novel strategies have the potential to substantially improve patient survival rates, offering a much-needed breakthrough in the fight against this deadly disease.

A promising pathway to progress

The research team’s dedication and their focus on translating scientific discoveries into clinical therapies provide a promising pathway to improving patient outcomes. With their novel therapeutic strategies, they aim to achieve significant progress in the treatment of brain tumors within five years, beginning in Australia. This timeline offers hope for delivering more effective treatments to patients sooner rather than later.

Projects you can support

Given the current lack of sufficient treatment options, especially for pediatric patients, there is a critical need for new therapies. By supporting theses projects, you are contributing to an effort that could dramatically change the landscape of brain cancer treatment, providing hope for those affected by this devastating disease.

Female in research lab
PROJECT 1: Bioengineered dendritic cell-based cancer vaccine against brain tumours
We’ve developed an innovative cancer vaccine by bioengineering dendritic cells (DCs), the body’s immune system orchestrators, using an adenoviral vector. These enhanced DCs boost the immune system's ability to specifically target and destroy brain cancer cells with a single dose. This approach offers a precise, effective treatment that could significantly improve survival rates while reducing the side effects of traditional therapies.
Female in research lab
PROJECT 2: Combinatory viro-immunotherapy
Although viro-immunotherapies have shown promising results in the USA, with survival rates increasing more than fivefold, there has been a lack of clinical application in Australia. In response, we have developed a unique viro-immunotherapeutic vector that not only selectively targets and kills tumour cells but also stimulates and strengthens anti-tumour immune responses simultaneously. This innovative approach has the potential to significantly improve treatment outcomes for cancer patients in Australia.
Donate to Brain Cancer Therapy Research
Research lab
Our goal

With our new brain cancer-specific therapeutic approaches, we aim to significantly improve treatment outcomes for Australian brain tumour patients.

Our goal is to make a meaningful impact within the next five years.

- Dr. Julius W. Kim

About Dr. Julius W. Kim

Supporting Dr. Julius W. Kim’s research is crucial due to his unique skill set in genetically modifying adenoviral vectors, a highly specialised technique that only a few researchers globally can perform with such precision to maximise efficacy. He also brings extensive translational research experience, from developing patentable vectors in the lab to advancing them into clinical trials. Furthermore, Dr. Kim leads a dedicated and passionate research team at the Kolling Institute and Royal North Shore Hospital, ensuring a strong and focused effort towards improving treatments for brain cancer.

Asian man in research lab
Dr. Julius W. Kim
View bio
Helpful Information
About
Get Involved
Make a Donation
Donate

You can shape the future
of healthcare for all

Give a gift that makes a real difference to our healthcare staff and facilities so they can deliver the best patient care.
Donate
Skip to content